Introduction
Laryngeal squamous cell carcinoma (SCC) accounts for 1.9% of cancers worldwide. Most of these are glottic (51%) of which a great many (up to 60%) are diagnosed in the early stages (T1-T2, N0, M0) as a result of noticeable voice changes that underlie lesions in true vocal cords. [2] [3] [4] For these locally spread laryngeal tumors, a laryngeal function preserving option is preferable. As a consequence, the National Comprehensive Cancer Network
Guidelines recommend the use of either radiotherapy or partial laryngectomy. However, whereas the latter is usually performed by carbon dioxide laser. 6 The choice between an open neck or transoral approach is very challenging because of the extreme heterogeneity of the lesions and the range of patient-specific variables.
OPHL is able to partially spare laryngeal function without compromising locoregional control 8, 9 reaching a good compromise between oncological radicality and functional outcome. To standardize the procedure, the European Laryngological Society recently proposed a classification of the more commonly adopted OPHL according to extent of resection (Type I -supraglottic, Type II -supracricoid, and Type III -supratracheal).
On the other hand, the advantages of TLM in terms of laryngeal preservation rate and early and faster recovery of laryngeal functions have already been reported, as well as the negative impact on local control for T3 lesions extending laterally to the thyroarytenoid (TA) muscle, with involvement of the paraglottic space (PGS). 7, [11] [12] [13] [14] The heterogeneity in terms of local extent and prognosis of glottic cT2 tumors is well 15 They demonstrated that unimodal endoscopic laser resection provides a good oncological outcome in the majority of cT2; in contrast, tumors upstaged as pT3 for involvement of the PGS, represent a completely different disease, which negatively influences prognosis. 15 Based on these observations, we followed the staging policy and the sub-classification of cT2 proposed by Peretti and colleagues in a cohort of patients treated by OPHL, with the aim of emphasizing the role of OPHL in patients affected by T2 and selected T3, and comparing the oncological and functional outcomes with those obtained by TLM.
Hence, a multicentric retrospective outcomes analysis of 216 patients with glottic laryngeal SCC classified as cT2 and managed by Type II-III OPHLs is presented. The analysis was conducted over a 16-year period during which TLM or radiotherapy were applied as alternative therapeutic options.
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Material and methods
Patients
All patients were from the Hospital of Vittorio Veneto (Treviso) or the Martini Hospital of Turin (Italy). Selection was based on a routinely performed clinical assessment lasting 3 weeks prior to surgery, in order to evaluate the superficial and depth extent of the tumor, as previously described. Vocal fold mobility assessment resulted in 71 cases with normal vocal cord mobility, and 145 cases with impaired vocal cord mobility and mobile cricoarytenoid joint.
All patients were submitted to neck computed tomography (CT) or magnetic resonance imaging (MRI) to rule out infiltration of the cartilaginous framework and evaluate the extent of the pre-epiglottic space and/or paraglottic space.
The preoperative records, radiologic images as well as all surgical specimens were retrospectively reviewed to allow the reclassification of all cases, according to the UICC/AJCC classification. Moreover, after the final histology, the entire cohort of cT2 were divided into five subtypes as suggested by Peretti and colleagues (Fig. 1) . 15 
Surgery
Open neck procedures were classified according to the European Laryngological Society In all patients, resection margins were examined intraoperatively with frozen sections:
when positive, the resection was expanded until the margins were negative. The margins of the surgical specimen were always checked again upon definitive pathology. The interventions were conducted using the principles of a modular approach. The resection is always prepared in standard mode and the larynx is opened from the side less affected by disease. At this point, under visual control, the subsites involved are removed and the resection can be enlarged as follows: (1 Table 1) .
Postoperative care
All patients were monitored for early complications (local and general) and late sequelae.
Patients underwent the same rehabilitation protocol, apart from those with serious early complications. The postoperative protocol was in accordance with our previous report.
Briefly, this was: (1) A large volume encompassing the primary site and all draining lymph nodes was irradiated with a dose of up to 54 Gy/2 Gy. Regions at higher risk for malignant dissemination received a 12-Gy boost (total 66 Gy/2 Gy -range 62-68 Gy). Six of 9 patients (5 pN+ with extracapsular spread, and 1 multiple positive margins toward cricoid) also received 100 mg/m 2 cisplatin on days 1, 22, and 43 of the course of radiotherapy. 27 Larynx oncologic and functional assessment All patients were followed for a mean period of 5.71 years with periodic videolaryngoscopic examinations, scheduled every 3 months in the first 3 years and with decreasing frequency in the subsequent period.
During the 5 postoperative years, Pearson's Scale evaluation was repeated and larynx functional status was evaluated with the Performance Status Scale. 28 The latter is a simple, practical, clinician-rated assessment tool consisting of three subscales: speech comprehension, normalcy of diet and eating in public, graduated from 0 to 100 on the basis of predefined parameters.
Statistical methods
Overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), locoregional control (LRC), local control (LC), laryngectomy-free survival (LFS) and laryngeal function preservation (LFP), were assessed by means of Kaplan-Meier curves.
Log-rank and Gehan-Breslow-Wilcoxon tests (for early events) were used to compare Kaplan-Meier estimates between groups (cT2 subtypes, clinical history of previous treatment, type of surgery, and age). The end points considered were obtained as the length of time from the date of diagnosis to: OS) the date of death; DFS) the date of the first recurrence; DSS) the date of death from the disease; LRC) the date of the first locoregional recurrence; LC) the date of the first local recurrence; LFS) the date of total laryngectomy; LFP) the date of total laryngectomy or presence of tracheostomy, NG tube, gastrostomy feeding, or non-intelligible voice.
All analyses were performed with GraphPad Prism version 5.00 (GraphPad Software, San Diego, CA, USA), with p < 0.05 as the statistically significant cut-off. In particular, in subtype I, no recurrences were observed. In subtype II, one local recurrence was observed among 13 patients. The patient was successfully treated by TLM and was free from recurrence at 46 months. In the subtype III, 3 out of 40 patients (7.5%) experienced local (1), regional (1), or locoregional (1) recurrences. Salvage therapy for local recurrence included total laryngectomy and adjuvant chemoradiation therapy. The first patient died of other disease 15 months later; the second patient showed a second recurrence 22 months later and died of the disease 8 months later, while the third is free of disease at 32 months. Among the patients with regional recurrence (neck), both were previously classified as pN0. At the time of primary resection, both received monolateral neck dissection. One recurrence was observed at the VI level. Recurrences in the neck were treated with surgery and radiation therapy; one patient died as a result of regional recurrences 22 months later, and one is alive and disease-free. In the subtype IV, 1 out of 116 patients (0.9%) experienced both local and regional recurrences. The patient was previously classified as pN0 and was treated with surgery, including total laryngectomy, and radiation therapy; the patient died as a result of distant metastases. In the subtype V (cT2/pT3), among 36 patients, there was 1 patient (previously classified as pN0) suffering from both local and regional recurrences (2.7%). Salvage therapy included total laryngectomy and adjuvant chemoradiation therapy, but the patient died of the disease 14 months later. Overall, lymph node metastases were detected in 9/204 patients (4.4%), of whom 4 (2.0%) had multiple metastases.
RESULTS
Pathology, survival and disease control
The 5-year OS, DSS, LRC and LC were 93.1%, 98.0%, 97.1%, and 97.5%, respectively (Fig. 2) . A total of 13 patients had died: 4 of them for the laryngeal cancer and 9 from unrelated causes ( Table 2) . As DFS and LRC were overlapping in our patient cohort, we only reported LRC in our analyses.
Although DSS prevalence 5 years after surgery was not affected by any of the variables analyzed, the history of previous treatment and the employment of more invasive surgery provided small but significant impairments in both local and regional control (the former also as an early event, p < 0.01, Gehan-Breslow-Wilcoxon test) (Fig. 3) .
Postoperative course and morbidity
Overall acute complications during hospitalization occurred in 18 out 216 patients (8.3%) and there were no perioperative deaths. The mean hospitalization time for patients with acute complications was 29 ± 6 days, which was significantly longer than that for patients without acute complications (19 ± 4 days). Late sequelae following discharge were observed in 26 out of 216 cases (12.0%) ( Table 3 ). All were successfully treated with TLM (8/10, 80%), and injective laryngoplasty using Vox-implants, which successfully treated dysphagia (2/10, 20%).
Laryngeal function preservation
At 5 years after surgery, LFP was maintained in 97.8% of patients whereas the use of total laryngectomy was avoided in 98.5% (Fig. 4) . In addition, we evaluated whether pT subtypes, previous treatment, age, and the type of surgery could affect LFP or even the use of total laryngectomy (Table 4) Overall, AP was observed in 6/216 cases (2.8%), 4 cases during hospitalization and 2 cases during follow-up. Completion of total laryngectomy for persistent aspiration was not required in any patient. Two patients were subjected to the endoscopic procedure of injective laryngoplasty using Vox implants, which successfully resolved the dysphagia.
The mean time to intermittent occlusion of the tracheostomy was 22.6 days (range 5-166 days), and the average time to tracheostomy closure was 71.4 days (range 21-198 days).
In our protocol, progressive closure of the tracheostomy is preferred, and occurs spontaneously in the majority of patients following occlusion. For patients, especially in the first weeks after discharge, this leads to a sensation of greater safety concerning minor episodes of food inhalation, which are relatively frequent. When the tracheostomy has almost closed, minor plastic surgery can then be performed.
DISCUSSION
In the early 1970s, by systematically applying whole organ sections in the study of total laryngectomy specimens, Kirchner, Oloffson and colleagues well described the patterns of spread of laryngeal cancer. According to the literature on transoral laser treatment for intermediate staged glottic
cancer (T2/T3), TLM has shown a signicant increase of recurrences in those cases with involvement of PGS and impairment and/or fixation of the true vocal cords. [13] [14] [15] In a study of 55 patients with glottic cT2, Peretti et al. 15 concluded that TLM can be considered effective when the pT2 stage has been confirmed. By contrast, in cT2/pT3 patients, after the first transoral resection that allows the correct pT staging, additional treatment should always be considered. In a cohort of 167 patients treated by TLM, Ambrosch 6 reported a local control rate of 74% and a laryngectomy rate of 13.4% in 97 patients staged pT2 while a 5-year local control rate of 68% and laryngectomy rate of 14.3% was observed in 70 patients staged pT3. Canis et al. reported a retrospective study of 391 previously untreated patients affected by glottic cT2/T3: they noted a 93% larynx preservation rate among pT2a and 83% among pT2b and pT3 tumors.
Preoperative under-staging, in the glottic cT2 category, occurs with some frequency because of misinterpretation of radiologic data among patients with suspected involvement of PGS; the lack of sensitivity on early PGS involvement is greater using CT-scan compared to MRI. 
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Figure1. Graphical representation of T2 glottic carcinoma subtypes: (I) pT2 with superficial supraglottic extension to the base and roof of the ventricle and/or ventricular band; (II) pT2 with superficial lateral subglottic extension; (III) pT2 with anterior supracommissural and/or subcommissural extension; (IV) pT2 with deep thyroarytenoid (TA) muscle infiltration; (V) pT3 for superior and/or inferior PGS invasion lateral to the thyroarytenoid muscle. 189x51mm (300 x 300 DPI) Figure 3 . Patient cohort stratification for pT subtypes (first column), history of previous treatment (second column), age (third column), and type of surgery (fourth column) using Kaplan-Meier curves. The end points considered were (from top to bottom) disease-specific survival, locoregional control, and local control. *p < 0.05; **p < 0.01. 112x66mm (600 x 600 DPI) 
